| The renal cell carcinoma market: Votrient to challenge Sutent's lead - InPharm |
|
|
InPharm Coloured urogram (X-ray) of the left kidney of a patient with renal clear cell carcinoma (blue). Credit: Sovereign, ISM/Science Photo Library After decades ... http://www.inpharm.com/news/101125/renal-cell-carcinoma-market-votrient-sutent |